Selecting the Right Patient for Surgical Treatment of Hyperhidrosis

Cameron, A. E. P.

doi:10.1016/j.thorsurg.2016.06.004

Cited by 15 publications

(13 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…HH has a major impact on the quality of life of these patients, affecting both their personal and professional relationships. 1,2 In most cases, HH presents with initial symptoms in childhood and adolescence and persists throughout adulthood, with patients seeking medical care more often during their economically active ages. 3,4 Treatment with oral anticholinergics, especially oxybutynin, generates clinical improvement in most patients and is also effective in patients over 40 years of age; these agents are the first treatment option for HH and are primarily used in patients over the age of 40 who prefer noninvasive treatment to avoid the risks of surgery.…”

mentioning

confidence: 99%

Analysis of the Results of Videotoracoscopic Sympathectomy in the Treatment of Hyperhidrosis in Patients 40 Years or Older

Faustino

Campos

Kauffman

et al. 2020

Annals of Vascular Surgery

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Analysis of the Results of Videotoracoscopic Sympathectomy in the Treatment of Hyperhidrosis in Patients 40 Years or Older

Faustino

Campos

Kauffman

et al. 2020

Annals of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…The current contraindications to VATS are: Lung infections that can evolve with pleural effusion and require puncture or drainage, dense pleural adhesions caused by lung diseases as tuberculosis, previous thoracic surgeries, thoracic radiotherapy, sinus bradycardia, clinical situations leading to contraindication to endotracheal anesthesia and obesity (31).…”

Section: Contraindications For Vatsmentioning

confidence: 99%

Upper extremity sympathectomy

Campos¹,

Kauffman²,

Faustino³

et al. 2018

J. Vis. Surg.

View full text Add to dashboard Cite

Hyperhidrosis is a condition in which there is excessive production of sweat that is disproportional to thermoregulation needs and that profoundly hampers the quality of life (QOL) of the population that is affected by it. The disorder is typically limited to the palms, the plantar and craniofacial regions, armpits, and manifests itself in a symmetrical fashion in addition to being associated to family history. At present, sympathectomy is considered the golden standard treatment and there are a number of approaches a surgeon may elect to adopt in its care. The clinical treatment with oxybutynin also improves screening of the group of patients that will benefit the most with this indication. However, the efficacy of the surgical method, what most counts for a successful outcome is the occurrence or not of compensatory hyperhidrosis whose intensity may impact the results. All patients are and must be thoroughly informed of this possibility prior to surgery. For the others indications, is also one of the final approaches necessary for a fruitful treatment.

show abstract

“…In a very stressful society, sweating increases as a direct adrenergic response to the sympathetic nervous system and has become a frequent complaint in our daily medical practice. 1 Hyperhidrosis (HH) is defined as sweating exceeding the necessary amount to meet the body's thermal regulation and physiological needs. It is characterized by excessive sweating in a specific region due to sweat gland hyperfunctioning, directly affects quality of life, and compromises the patient emotionally, socially, and professionally.…”

Section: Introductionmentioning

confidence: 99%

“…HH can be classified as primary or secondary. 1,2 Primary HH has no known cause, is usually bilateral and symmetrical, improves during sleep, and worsens in situations of stress, anxiety, fear, and nervousness. It may have a related genetic predisposition as evidenced by its familial transmission through dominant autosomal genes.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Current treatment options for craniofacial hyperhidrosis

et al. 2020

View full text Add to dashboard Cite

Hyperhidrosis (HH) is characterized by sweating exceeding the amount necessary to meet the thermal regulation and physiological needs of the body. Approximately 9.41% of individuals with HH have craniofacial hyperhidrosis (FH). The present study aims to review the most current data in the literature regarding craniofacial hyperhidrosis, including pathophysiology, diagnosis and clinical presentation, treatment options (clinical and surgical), and outcomes. VATS (videothoracoscopy sympathectomy) is considered the gold standard for definitive treatment of axillary or palmar hyperhidrosis. Recently, several studies have shown the usefulness of clinical treatment with oxybutynin hydrochloride, leading to clinical improvement of HH in more than 70% of users. Both clinical and surgical treatment of craniofacial hyperhidrosis have good results. However, surgical treatment of FH is associated with more complications. Clinical treatment with oxybutynin hydrochloride yields good results and can be the first therapeutic option. When the patient is not satisfied with this treatment and has good clinical conditions, surgical treatment can be used safely.

show abstract

Selecting the Right Patient for Surgical Treatment of Hyperhidrosis

Cited by 15 publications

References 18 publications

Analysis of the Results of Videotoracoscopic Sympathectomy in the Treatment of Hyperhidrosis in Patients 40 Years or Older

Analysis of the Results of Videotoracoscopic Sympathectomy in the Treatment of Hyperhidrosis in Patients 40 Years or Older

Upper extremity sympathectomy

Current treatment options for craniofacial hyperhidrosis

Contact Info

Product

Resources

About